Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Renal Cell Cancer AJCC v8”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00541008
What this trial is testing

Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer

Who this might be right for
Kidney Cancer
UNICANCER 92
Early research (Phase 1)Study completedNCT02166255
What this trial is testing

APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaRecurrent Pancreatic CancerRecurrent Renal Cell Cancer+9 more
Wake Forest University Health Sciences 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT05012371
What this trial is testing

Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more
M.D. Anderson Cancer Center 90
Testing effectiveness (Phase 2)Study completedNCT00003551
What this trial is testing

Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer

Who this might be right for
Kidney Cancer
Emory University
Testing effectiveness (Phase 2)Ended earlyNCT00684996
What this trial is testing

Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Recurrent Renal Cell CancerRenal Cell CarcinomaStage III Renal Cell Cancer+1 more
National Cancer Institute (NCI) 5
Early research (Phase 1)Study completedNCT00004890
What this trial is testing

Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer

Who this might be right for
Drug ExtravasationKidney Cancer
BioMedicines
Early research (Phase 1)Not Yet RecruitingNCT07716735
What this trial is testing

Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer

Who this might be right for
Advanced Kidney CarcinomaAdvanced Renal Cell CarcinomaHereditary Leiomyomatosis and Renal Cell Carcinoma+6 more
Jonsson Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)Looking for participantsNCT06447103
What this trial is testing

An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage II Renal Cell Cancer+2 more
Jonsson Comprehensive Cancer Center 91
Early research (Phase 1)Study completedNCT00005816
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer

Who this might be right for
Kidney Cancer
Duke University 15
Testing effectiveness (Phase 2)Ended earlyNCT00098618
What this trial is testing

Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaPapillary Renal Cell CarcinomaRecurrent Renal Cell Cancer+2 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00058318
What this trial is testing

S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer

Who this might be right for
Kidney Cancer
SWOG Cancer Research Network 43
Early research (Phase 1)Study completedNCT00004178
What this trial is testing

Gene Therapy in Treating Patients With Cancer

Who this might be right for
Cancer
Roger Williams Medical Center
Testing effectiveness (Phase 2)Study completedNCT00354250
What this trial is testing

Ispinesib in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Recurrent Renal Cell CancerStage III Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 60
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT02318771
What this trial is testing

Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Renal Cell CancerRecurrent Head and Neck Carcinoma+6 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 41
Testing effectiveness (Phase 2)Study completedNCT01158521
What this trial is testing

Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaStage I Renal Cell CancerStage II Renal Cell Cancer+1 more
Case Comprehensive Cancer Center 25
Early research (Phase 1)Ended earlyNCT00014131
What this trial is testing

Vaccine Therapy in Treating Patients With Kidney Cancer

Who this might be right for
Kidney Cancer
Lisata Therapeutics, Inc. 9
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT04902040
What this trial is testing

Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies

Who this might be right for
Advanced Bladder CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid Neoplasm+32 more
M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT00121251
What this trial is testing

Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney Cancer

Who this might be right for
Recurrent Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v7Stage IV Renal Cell Cancer AJCC v7
National Cancer Institute (NCI) 17
Next Page